Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Quote. Delayed Nasdaq - 10/29 04:00:00 pm
33.52 USD   -3.09%
12:09pWALGREENS BOOTS ALLIANCE : Declares Quarterly Dividend
BU
06:47aUber and HSBC wins help trading improve at ad group WPP
RE
06:23aUber and HSBC wins help trading improve at ad group WPP
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 34.7 USD in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 34.67 support.
  • The stock, which is currently worth 2021 to 0.31 times its sales, is clearly overvalued in comparison with peers.
  • Its low valuation, with P/E ratio at 9.26 and 8.4 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company is one of the best yield companies with high dividend expectations.
Weaknesses
  • The company sustains low margins.
  • Analysts covering the stock have recently lowered their earnings forecast.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Below the resistance at 45.35 USD, the stock shows a negative configuration when looking looking at the weekly chart.
Ratings chart
Sector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
WALGREENS BOOTS ALLIANCE, I..-41.33%29 952
MCKESSON CORPORATION4.18%23 372
CARDINAL HEALTH, INC.-9.13%13 484
DASHENLIN PHARMACEUTICAL GR..97.79%8 401
WELCIA HOLDINGS CO., LTD.19.71%8 333
SINOPHARM GROUP CO., LTD.-35.04%7 432
HUADONG MEDICINE CO., LTD16.32%7 375
YIFENG PHARMACY CHAIN CO., ..77.30%7 319
SHANGHAI PHARMACEUTICALS HO..9.80%7 214
JOINTOWN PHARMACEUTICAL GRO..29.05%4 968
CHINA NATIONAL MEDICINES CO..59.51%4 881
MATSUMOTOKIYOSHI HOLDINGS C..-6.61%3 892
MEDIPAL HOLDINGS CORPORATIO..-21.18%3 828
CLICKS GROUP LIMITED-8.41%3 578
YIXINTANG PHARMACEUTICAL GR..62.85%3 316
SUZUKEN CO., LTD.-16.80%3 176
More Results
Financials (USD)
Sales 2021 143 B - -
Net income 2021 3 175 M - -
Net Debt 2021 13 736 M - -
P/E ratio 2021 9,26x
Yield 2021 5,49%
Capitalization 29 952 M 29 952 M -
EV / Sales 2021 0,31x
EV / Sales 2022 0,29x
Nbr of Employees 277 000
Free-Float 61,2%
Upcoming event on WALGREENS BOOTS ALLIANCE, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes